Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AD Pharma AB
AB
Active
Org 5595024836
Solbacken 3, 641 52
Katrineholm
Retail sale of pharmaceutical products
· NACE 4773
Est. 2024
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
AD Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
508
Staff expenses
−402
EBITDA
56
Depreciation & amort.
—
EBIT
56
Net financials
−0
Profit before tax
56
Tax
−11
Net profit
44
Balance sheet
SEK thousands
Item
2025
Total assets
205
Equity
69
Long-term debt
—
Short-term debt
135
Total debt
135
Financial ratios
5-year trend
EBITDA margin
10.9%
This company
15.8%
Market median
-31% vs market
2025
2025
Equity ratio
33.8%
This company
38.2%
Market median
+12% vs market
2025
2025
Return on equity
63.8%
This company
18.4%
Market median
+247% vs market
2025
2025
Net profit margin
8.7%
This company
8.1%
Market median
+7% vs market
2025
2025
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
2025
2025
Debt / equity
1.96×
This company
0.62×
Market median
-216% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-30 – 2025-10-31
View
PDF
More on AD Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
